Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    supriya kashyap kashyap
    supriya kashyap kashyap
      • Home
      • supriya kashyap...

      Articles By : supriya kashyap kashyap

      Sun Pharma shows Positive Results in Phase-3 Clinical Trial for Dry Eye drug

      Sun Pharma shows Positive Results in Phase-3 Clinical Trial for Dry Eye drug

      supriya kashyap kashyap6 Jan 2017 10:45 AM IST
      Seciera™ Meets Primary and Key Secondary Endpoints in Pivotal Trial Shows Efficacy at 12 Weeks of Treatment Sun Pharma is Developing Seciera™ for...
      Natco launches generic Hepatitis C drug Velpanat in Nepal

      Natco launches generic Hepatitis C drug Velpanat in Nepal

      supriya kashyap kashyap6 Jan 2017 10:43 AM IST
      New Delhi : Natco Pharma has launched a generic Hepatitis C treatment drug in Nepal under the brand name 'Velpanat.'The product is the first generic...
      New drug approvals fall to six year low in 2016

      New drug approvals fall to six year low in 2016

      supriya kashyap kashyap6 Jan 2017 10:43 AM IST
      London : Last year turned out to be a disappointing one for new drug approvals with the U.S. Food and Drug Administration clearing just 22 new...
      Sanofi Pasteur and MSD end joint vaccines business in Europe

      Sanofi Pasteur and MSD end joint vaccines business in Europe

      supriya kashyap kashyap6 Jan 2017 10:43 AM IST
      Paris : Sanofi and its vaccines global business unit Sanofi Pasteur confirmed the end of their vaccine joint-venture with MSD (known as Merck &...
      Judge halves 1 billion dollars award in Johnson and Johnson hip implants case

      Judge halves 1 billion dollars award in Johnson and Johnson hip implants case

      supriya kashyap kashyap5 Jan 2017 12:47 PM IST
      A US judge almost halved the award in a December jury verdict that ordered Johnson & Johnson (JNJ.N) and its DePuy Orthopaedics unit to pay more...
      Bill Gates invests USD 140 million in HIV cure

      Bill Gates invests USD 140 million in HIV cure

      supriya kashyap kashyap5 Jan 2017 12:41 PM IST
      Houston : Microsoft founder Bill Gates' charity foundation has invested USD 140 million in the development of HIV preventing drug implants that could...
      USFDA issues warning letter to Wockhardt

      USFDA issues warning letter to Wockhardt's Ankleshwar plant

      supriya kashyap kashyap5 Jan 2017 12:40 PM IST
      New Delhi : The US Food and Drug Administration (USFDA) has issued a warning letter to Wockhardt for violating current good manufacturing practice...
      Jubilant Life signs deals for diagnostic product supply

      Jubilant Life signs deals for diagnostic product supply

      supriya kashyap kashyap5 Jan 2017 12:39 PM IST
      New Delhi : Jubilant Life Sciences said its subsidiary had signed long-term contracts in the US for supply of some of its diagnostic and therapeutic...
      Lupin gets FDA nod for generic drug to treat Sjogrens symptom

      Lupin gets FDA nod for generic drug to treat Sjogren's symptom

      supriya kashyap kashyap4 Jan 2017 12:08 PM IST
      New Delhi : Drug firm Lupin has received final approval from the US health regulator to market cevimeline hydrochloride capsules, used for treatment...
      Suven Life Sciences secures two Product Patents in Eurasia and Norway

      Suven Life Sciences secures two Product Patents in Eurasia and Norway

      supriya kashyap kashyap4 Jan 2017 12:02 PM IST
      Hyderabad : Suven Life Sciences Ltd announces that the grant of one (1) product patent from Eurasia (025136) and one (1) product patent from Norway...
      Panacea Biotec up 5 percent as it raises supply of life saving drug

      Panacea Biotec up 5 percent as it raises supply of life saving drug

      supriya kashyap kashyap4 Jan 2017 11:57 AM IST
      New Delhi : Shares of Panacea Biotec surged 5 per cent after the company said it has increased availability of life saving drug Cilamin 250 capsules...
      ADEH asks Government to review pricing of coronary stents

      ADEH asks Government to review pricing of coronary stents

      supriya kashyap kashyap4 Jan 2017 11:55 AM IST
      New Delhi : Expressing serious concern over affordability in health care, a network of doctors asked the Centre to review pricing of coronary stents...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok